Protagonist Therapeutics Ownership | Who Owns Protagonist Therapeutics?


OverviewForecastRevenueFinancialsChart

Protagonist Therapeutics Ownership Summary


Protagonist Therapeutics is owned by 117.24% institutional investors, 0.71% insiders. Blackrock funding, inc. /de is the largest institutional shareholder, holding 15.84% of PTGX shares. iShares Core S&P Small-Cap ETF is the top mutual fund, with 5.69% of its assets in Protagonist Therapeutics shares.

PTGX Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockProtagonist Therapeutics117.24%0.71%-17.95%
SectorHealthcare Stocks 244.59%12.11%-156.70%
IndustryBiotech Stocks 379.61%11.70%-291.31%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Blackrock funding, inc. /de10.31M15.84%$1.26B
Farallon capital management6.35M9.75%$778.25M
Blackrock5.76M9.39%$199.52M
Vanguard group5.41M8.49%$472.83M
Rtw investments, lp5.06M7.78%$620.40M
Wellington management group llp3.42M5.25%$418.83M
Ubs group3.40M5.22%$416.68M
State street3.32M5.10%$407.16M
Janus henderson group2.89M4.55%$304.87M
Vanguard capital management2.85M4.38%$349.77M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Johnson & johnson2.45M37.59%$300.22M
Lynx1 capital management lp700.01K9.47%$46.50M
Aquilo capital management81.69K7.08%$3.95M
Bvf inc/il2.56M6.90%$170.12M
Adar1 capital management960.86K5.39%$117.78M
Rtw investments, lp5.06M5.30%$620.40M
Eagle health investments lp248.32K5.05%$30.44M
Knott david m jr63.00K4.08%$7.72M
Farallon capital management6.35M3.59%$778.25M
Catalio capital management, lp106.80K2.46%$13.09M

Top Buyers

HolderShares% AssetsChange
Vanguard group5.41M0.01%1.16M
Sixth street partners management company583.77K0.01%583.77K
Blackrock funding, inc. /de10.31M0.02%528.47K
Price t rowe associates inc /md/2.15M0.03%484.17K
Franklin resources520.03K0.01%382.16K

Top Sellers

HolderShares% AssetsChange
Ubs group3.40M0.05%-1.78M
Deep track capital, lp---1.72M
Citadel advisors---1.55M
Fairmount funds management---931.89K
Bvf inc/il2.56M6.90%-650.13K

New Positions

HolderShares% AssetsChangeValue
Sixth street partners management company583.77K0.01%583.77K$71.56M
Eagle asset management357.63K0.07%357.63K$12.59M
Logos global management lp300.00K1.79%300.00K$19.93M
Stephens investment management group281.83K0.37%281.83K$34.55M
Macquarie management141.08K0.03%141.08K$17.29M

Sold Out

HolderChange
Tfc financial management-1.00
Root financial partners-3.00
Td capital management-4.00
Ifp advisors-5.00
Mendota financial group-6.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Jun 30, 20263536.33%76,307,719-3.10%1170.76%20522.75%87-19.44%
Mar 31, 2026324-1.82%76,383,7468.00%1200.98%163-11.41%1052.94%
Dec 31, 2025156-44.68%26,213,291-62.92%410.33%90-30.23%45-58.33%
Sep 30, 2025140-48.91%21,573,409-68.80%330.29%55-67.26%60-20.00%
Jun 30, 2025279-3.79%70,876,6488.54%1111.04%1673.73%78-13.33%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
iShares Core S&P Small-Cap ETF3.68M5.69%-1.43K
Vanguard Total Stock Mkt Idx Inv2.05M3.18%5.59K
Vanguard Morn Total Stk Mkt Idx Investor2.05M3.18%5.59K
Vanguard MStar Total Stk Mkt Idx Invest2.05M3.17%6.79K
Vanguard US Total Market Shares ETF1.87M3.05%129.62K
Pacer US Small Cap Cash Cows 100 ETF1.61M2.63%-11.71K
iShares Russell 2000 ETF1.56M2.41%-27.65K
Vanguard Small Cap Index1.48M2.29%3.81K
Vanguard Health Care Inv1.38M2.13%-177.65K
SPDR® S&P Biotech ETF983.05K1.58%2.19K

Recent Insider Transactions


DateNameRoleActivityValue
Sep 09, 2026PATEL DINESH V PH D President and CEOSell$9.29M
Sep 08, 2026PATEL DINESH V PH D President and CEOSell$7.90M
Sep 10, 2026PATEL DINESH V PH D President and CEOSell$1.05M
Aug 10, 2026PATEL DINESH V PH D President and CEOSell$9.81M
Aug 11, 2026PATEL DINESH V PH D President and CEOSell$5.09M

Insider Transactions Trends


DateBuySell
2026 Q3-5
2026 Q2-9
2026 Q1-18
2025 Q4-3
2025 Q3-6

PTGX Ownership FAQ


Who Owns Protagonist Therapeutics?

Protagonist Therapeutics shareholders are primarily institutional investors at 117.24%, followed by 0.71% insiders and -17.95% retail investors. The average institutional ownership in Protagonist Therapeutics's industry, Biotech Stocks , is 379.61%, which Protagonist Therapeutics falls below.

Who owns the most shares of Protagonist Therapeutics?

Protagonist Therapeutics’s largest shareholders are Blackrock funding, inc. /de (10.31M shares, 15.84%), Farallon capital management (6.35M shares, 9.75%), and Blackrock (5.76M shares, 9.39%). Together, they hold 34.98% of Protagonist Therapeutics’s total shares outstanding.

Does Blackrock own Protagonist Therapeutics?

Yes, BlackRock owns 9.39% of Protagonist Therapeutics, totaling 5.76M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 199.52M$. In the last quarter, BlackRock increased its holdings by 188.63K shares, a 3.39% change.

Who is Protagonist Therapeutics’s biggest shareholder by percentage of total assets invested?

Johnson & johnson is Protagonist Therapeutics’s biggest shareholder by percentage of total assets invested, with 37.59% of its assets in 2.45M Protagonist Therapeutics shares, valued at 300.22M$.

Who is the top mutual fund holder of Protagonist Therapeutics shares?

iShares Core S&P Small-Cap ETF is the top mutual fund holder of Protagonist Therapeutics shares, with 5.69% of its total shares outstanding invested in 3.68M Protagonist Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools